PHARMACOKINETIC AND BIOEQUIVALENCE COM-PARISON BETWEEN ARTEMETHER TABLETS 80MG: AN OPEN LABEL, BALANCED, RANDOMIZED-SEQUENCE, SINGLE-DOSE, TWO-PERIOD CROSS-OVER STUDY IN HEALTHY MALE VOLUNTEERS
Keywords:
Artemether, Bioavailability, Bioequivalence, Intrasubject VariabilityAbstract
Background: This present bioequivalence study was designed to determine the pharmacokinetic, bioavailability and bioequivalence of Artemether (80mg tablets in comparison with COARTEMTM Artemether (4x20mg) tablets after single dose administration under fed conditions in healthy adult male subjects. Therefore the design of an open label, balanced, randomized, two-sequence, single dose, two way crossover study with a wash-out period of at least 7 days was used.
Methods: An open-labeled, balanced, single-dose with food, two-treatment, two-period, two-sequence, randomized crossover study was conducted in 12 healthy male volunteers. Each volunteer received 80mg Artemether tablet of the reference or test drug respectively. On the day of dosing, blood samples were collected before dosing and at various time points up to 216 hours after dosing. Analysis of Artemether concentrations was performed using a validated liquid chromatography with tandem mass spectrometry (LC-MS/MS) method. The pharmacokinetic parameters including Cmax, AUC0-t, AUC0-inf, Tmax, t1/2 and Kel were analyzed using the non-compartmental model. Drug safety and tolerability were assessed.
Results: The pharmacokinetic parameters including Cmax, AUC0-t, AUC0-inf, Tmax, t1/2 and Kel were analyzed using the non-compartmental model. Drug safety and tolerability were assessed. The primary pharmacokinetic parameters (Cmax, AUC0-t, AUC0-inf) 90%CI were within the 80 to 125% interval required for bioequivalence as stipulated in the current regulations of the USFDA acceptance criteria. The geometric mean ratios (Test/Reference) between the two products of 80mg tablets under fed condition 105.7% (81.23%-110.58%) for Cmax ratios, 91.0% (90.43%-108.32%) for AUC0-t ratios, 84.8% (80.45%-104.98%) for AUC0-inf ratios of Artemether, respectively. 12 volunteers had completed both treatment periods. There was no significant difference of the Tmax parameter between the two formulations (p >0.05). No serious adverse events related to the study drugs were found.
Conclusion: This single dose study found that the test formulation Artemether 80mg tablets are bioequivalent to the reference formulation COARTEMTM Artemether (4x(20mg) tablets in terms of extent and rate of absorption, under fed condition in healthy adult male volunteers according to the USFDA regulatory guidance.
Downloads
References
Laxminarayan R, Parry IWH, Smith DL, Klein E. should new antimalarial drugs be subsidized. J health econ. 29, 2010; 445-456.
World Health Organisation [2006], WHO guidelines for the treatment of malaria. 2nd edition, 1 may 2010.
World health Organisation [2009]. World Malaria Report, 1 may 2010.
Jared N. Cumming, Poonsakdi Ploypraditha and Gary H. Posnera. Antimalarial activity of artemisinin [qinghaosu] and related trioxanes, mechanism[s] of action. Advances in pharmacology. 37, 1996; 253-297.
Washington DC, Institute of medicine of the national academies saving lives, buying time. Economics of malaria drugs in an age of resistance. National Academies Press, 2004.
Mccombie SC. Treatment seeking for malaria, a review of recent research. Soc Sci Med. 43, 1996; 933-945.
Williams HA, Jones CO. A critical review of behavioral issues related to malaria control in sub-Saharan Africa, Soc Sci Med. 59, 2004; 501-523.
Roll back malaria-2007[RBM], Affordable medicines facility-malaria [AMFm], 5 may 2010.
Talisuna A, Grewal P, Rwakimari JB, Mukasa S, Jagoe G, et al. Cost is killing patients, Subsidising effective antimalarials. Lancet. 374, 2009; 1224-1226.
Goodman C, Brieger W, Unwin A, Mills A, Meek S, et al. Medicine sellers and treatment in sub-Saharan Africa, Am J Trop Med Hyg. 77[6], 2007; 203-218.
Smith LA, Jones C, Meek S, Webster J. Provider practice and user behavior interventions to improve prompt and effective treatment of malaria, do we know what works, Am j Trop Med Hyg, 80[3], 2009; 326-335.
Oxfam. Challenging the myths about private healthcare in poor countries, Blind optimism. Oxfam briefing paper. 3 may 2010.
C.Hatz, S.Abdulla, R.Mull, D.Schellenberg, I.Gathmann, P.kibatala, H.P.Beck, M.Tanner, C.Royce. Efficacy and safety of CGP 56697 [artemether and benflumetol] compared with chlroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Tropical Medicine and Interantional Health. 3, 1998; 498.
MV Vugt, P Wilairatana, B Gemperli, I Gathmann, L Phaipun, A Brockman, C Luxemburger, NJ White, F Nosten, and S Looareesuwan. Efficacy of six doses of artemether-lumefantrine [benflumetol] in multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 60[6], 1999; 936-942.
Janssen Pharmaceutica Products. Sporanox [Lumefantrine] injection. US Food and Drug Administration, 2002.
Noor AM, Gething PM, Alegana VM, Patil A, Hay SI, et al. The risks of malaria infection in Kenya. BMC Infectious Diseases. 9, 2009; 180.
Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, et al. Malaria drug shortages in Kenya, a major failure to provide access to effective treatment. Am J Trop Med Hyg., 80, 2009; 737-738.
Van Vugt M, Looareesuwan S, Wilairatana P, MC Gready R, Villegas L, Gathmann I, Mull R, Brockman A, White Nj, Nosten F. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria, Transactions of the Royal Society of Tropical Medicine and Hygeine. 94[5], Sep-Oct 2000; 545-8.
Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, et al. Piloting the global subsidy, the impact of subsi-dized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania Plos one, 4[9], 2009; 6857.
Sabot O, Yeung S, Pagnoni F, Gordon M, Petty N,et al. Distribution of artemisinin-based combination therapies through private-sector channels, RFF Discussion Paper, 2009; 08-43.
Dalessandro U, Talisuna M, Boelaert M, Should artemisinin-based combination treatment be used in the home-based manaalaria, Trop Med Int Health. 10, 2005; 1-2.
Richard K. Haynes, Simone C. Vonwiller. Extraction of artemisinin and artemisinic acid, preparation of artemether and new analogues, Transactions of the Royal Society of Tropical Medicine and Hygiene, 88[1], June 1994; 23-26.
Dharmarajan Sriram, Vajja Sambasiva Rao, Kondapalli Venkata Gowri Chandrasekhar, Perumal Yogeeswari. Progress in the research of artemisinin and its analogues as antimalarials. Natural Product Research, formerly natural product letters, 18[6], 2004; 503-527.
World Medical Association Declaration Of Helsinki, Ethical Principles For Medical Research Involving Human Subjects, 59th WMA General Assembly, 2008
International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use, Guideline For Good Clinical Practice, E6, 1996
Raghunadha Reddy.S, Koteswara Rao.Divi, I.Sarath chandiran and K.N. Jayaveera. Quantification of Artemether in human plasma with liquid- liquid extraction by using fully validated high performance liquid Chromatography–Tandem mass spectrometric method, Journal of Pharmacy Research, August-2010, Voumel-3, Issue-8, Impact Factor-1.5, ISSN: 0974-6943.
Raghunadha Reddy.S, M.P. Kalyan Reddy, Y.K.Naidu, Koteswara Rao.Divi, I.Sarath Chandiran and K.N. Jayaveera. Development and Validation of High Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Quantification of Lumefantrine in Human Plasma with Precipitation, International Journal of Pharma Research and Development [IJPRD], Apr -2010, Volume-2, Issue-2, Page-1-9 and ISSN: 0974 – 9446.
U.S. Department of Health and Human Services Food and Drug Administration, Bioanalytical Method Validation, 2001.
U.S. Department of Health and Human Services Food and Drug Administration, Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations, 2003.
U.S. Department of Health and Human Services Food and Drug Administration, Statistical Approaches to Establishing Bioequivalence, 2001.
Raghunadha Reddy S, Koteswara Rao.Divi, I. Sarath Chandiran, K.N. Jayaveera, Y.K. Naidu, M.P. Kalyan Reddy. Development and validation of high-throughput liquid chromatography–tandem mass spectrometric method for simultaneous quantification of Clopidogrel and its metabolite in human plasma, Journal of Chromatography B, Elsevier Publications, February- 2010, volume-878, Issue:3-4, pages:502–508, Impact factor-2.977, ISSN: 1570-0232.
Y.K.N, Raghunadha Reddy Seelam, Koteswara Rao Divi, Penchala Kalyan Reddy Mule, Sarath Chandiran I and Jayaveera K N. Simultaneous Quantification of Alverine And Its Metabolite P-Hydroxy Alverine In Human Plasma With Robotic Liquid-Liquid Extraction By Using Fully Validated LC-MS/MS and Its Application To A Bioequivalence Study, Journal Of Pharmacy Research, 2010, Volume-3, Issue-6, Page-1407-1411, Impact Factor-1.5, ISSN: 0974-6943.
I.Sarath Chandiran, K. N. Jayaveera and Raghunadha Reddy. S., High-Throughput Liquid Chromatography–Tandem Mass Spectrometric Method for Simultaneous Quantification of Carvedilol and Its Metabolite 4-Hydroxyphenyl Carvedilol in Human Plasma and Its Application to Bioequivalence Study, Journal of Chemical and Pharmaceutical Research, , 2011, 3[2]:341-353, ISSN No: 0975-7384, CODEN[USA]: JCPRC5.
I.Sarath Chandiran, K. N. Jayaveera and Ragunadha Reddy. S. Development and Validation of High-Throughput Liquid Chromatography-Tandem Mass Spectrometric Method for Quantification of Itraconazole and its Metabolite in Human Plasma. Scholars Research Library, Der Pharmacia Lettre, 2011, 3[2]: 316-328.
I.Sarath Chandiran K.N. Jayaveera and Raghunadha Reddy.S, Pharmacokinetic and Bioequivalence Comparison Between Extended Release Capsules of Venlafaxine Hydrochloride 150mg: An Open Label, Balanced, Randomized-Sequence, Single-Dose, Two-Period Crossover Study In Healthy Indian Male Volunteers, International Research Journal Of Pharmacy [IRJP], 2[3], 2011,262-269, ISSN 2230-8407.
Raghunadha Reddy. S, I. Sarath Chandiran, K. N. Jayaveera and Koteswara Rao. Divi. Quantification of Ursodeoxy Cholic acid in human plasma by using High performance liquid chromatography–tandem mass spectrometric method and its applications in pharmacokinetics, Journal of Chemical and Pharmaceutical Research, 2010, volume-2, issue-3, Pages:59-69 and ISSN No: 0975-7384.
Raghunadha Reddy Seelam, Sarath Chandiran I, Koteswara Rao Divi, Jayaveera K. N., Development and Validation of High Performance Liquid Chromatography-Tandem Mass Spectrometric Method for Simultaneous Quantification of Telmisartan in Human Plasma, International journal of pharmaceutical sciences and Drug Research, 2010, Volume-2, Issue-3, Pages: 188-192 and ISSN No: 0975-248X.
Raghunadha Reddy.S, I.Sarath chandiran, K.N. Jayaveera and Koteswara Rao.Divi. Quantification of ibuprofen in human plasma by using high throughput liquid chromatography–tandem mass spectrometric method and its applications in pharmacokinetics, scholars research library, archives of applied research, 2010, volume-2, issue-3, pages-101-111, ISSN-0975-508x,coden[USA] AASRC9.
Raghunadha Reddy.S, Koteswara Rao.Divi, Y.K.Naidu, I.Sarath Chandiran, k.N. Jayaveera and M.P.Kalyan Reddy. Development and validation of high-performance liquid chromatography tandem mass spectrometric method for quantification of Clonidine in human plasma, journal of chemical and pharmaceutical sciences, April - June’2010, volume-3, issue-2.
Y.K.N, Raghunadha Reddy S., Koteswara Rao Divi, M.P. Kalyan Reddy, I. Sarath Chandiran and K.N. Jayaveera. Quantification of Levetiracetam in Human Plasma with Precipitation Extraction by Using Fully Validated LC-MS/MS and Its Application to a Bioequivalence Study, Research J. Pharm. and Tech., July-Sept 2010, Volume-3, Issue-3, and Page: 847-853 and ISSN: 0974-3618.
S.Raghunadha Reddy, Pobba Rajani, Koteswararao. Divi, YK Naidu, Sarath Chandiran I and MP Kalyan Reddy. Anti- inflammatory and analgesic activity of Smilax chinensis, Research Journal of Pharmaceutical, Biological and Chemical Sciences, April – June 2010, Volume-1, Issue-2, Pages: 1-8, ISSN: 0975-8585.
Kalyan Reddy MP, Jaya Chandra Reddy P, Raghunadha Reddy S, Jayaveera KN. Development and validation of bio-analytical method for Quantification of Pantoprazole in human plasma using LC-MS/MS, Journal of Pharmacy and Chemistry, July - September 2010,Volume-4, Issue-3, Pages:80-86 and ISSN No: 0973-9874.
Raghunadha Reddy S, Naidu YK, Koteswara Rao Divi, Ravikiran V, Sandhya Rani Y, Kalyan Reddy MP. Development and Validation of High Performance Liquid Chromatography Tandem Mass Spectrometric Method for Quantification of Aceclofenac in Human Plasma, Journal of Pharmacy and Chemistry, July - September 2010, Volume-4, Issue-3, Pages:89-95 and ISSN No: 0973-9874.
Mahitej Yadav Katteboina, Nageswara Rao Pilli, Ramesh Mullangi, Raghunadha Reddy Seelam and Shobha Rani Satla, LC-MS/MS assay for the determination of lurasidone and its active metabolite, ID-14283 in human plasma and its application to a clinical pharmacokinetic study, 10 November 2015, Biomed. Chromatogr.
I. Sarath Chandiran, Raghunadha Reddy Seelam, Seelam Sai Satyanaraya Reddy, Ravindra Reddy S, Bioequivalence and Pharmacokinetic Comparison between Extended Release Capsules of Carvedilol Phosphate 40mg: An Open Label, Balanced, Randomized- Sequence, Single-Dose, Two-Period Crossover Study in Healthy Male Volunteers, International Journal of Medicine and Pharmaceutical Research, 2015, 3(4): 1105–1114.
Raghunadha R Seelam, Sarath C Irisappan, Ravindra R Seelam, Sai SR Seelam, Bioequivalence comparison between two different Formulations of alverine citrate 120mg capsules: an open Label, balanced, randomized-sequence, single-dose, two period Crossover study in healthy male volunteers, Journal of Comprehensive Pharmacy, 2015, 2(3), 105-114.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
